FindTrial
Sign In

Clinical study of autologous menstrual blood stromal stem cells transplantation on treating endometrial damage

Application and molecular mechanism research on treating endometrial damage through autologous menstrual blood stromal stem cells transplantation combining with Bushenzhuyun Soup

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONB-15007464
Enrollment
Unknown
Registered
2015-11-25
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial damage

Interventions

before and after transplantation:Autologous MenSCs transplantation

Sponsors

Shengjing Hospital affiliated to China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. aged 20-40; 2. infertility due to endometrial damage of women; 3. failed to regenerate the endometrium in other treatments such as hormonal therapy, intrauterine device, aspirin or traditional chinese medicine.

Exclusion criteria

Exclusion criteria: 1. acute urogenital infection; 2. combined with other genital disease ingcluding hysteromyoma, adenomyosis, hydrosalpinx or body disease that could not bear pregnancy.

Design outcomes

Primary

MeasureTime frame
endometrial thickness;endometrial morphology;subendometrial zone vascularity;conception rate;—

Countries

China

Contacts

Public ContactJichun Tan
tjczjh@163.com+86 18940251868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026